Corporate Corruption Media ArticlesExcerpts of Key Corporate Corruption Media Articles in Major Media
Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
Just two days after the U.S. ended its 20-year war in Afghanistan, more than a dozen Democrats with strong ties to the military establishment defied President Joe Biden and voted to add nearly $24 billion to the defense budget for fiscal year 2022. On Wednesday, 14 Democrats joined 28 Republicans on the House Armed Services Committee to adopt an amendment from Rep. Mike Rogers, R-Ala., to the fiscal year 2022 defense authorization bill that would boost Biden's $715 billion spending proposal to $738.9 billion. The move follows the Senate Armed Services Committee's vote to similarly raise the top line to more than $740 billion in its July markup of the bill. Many of the Democrats who voted for the $24 billion increase have close ties to the defense establishment. Their districts are home to job-promoting manufacturing sites and military bases. Many of the Democrats have also received generous campaign donations from contractors. In fact, Federal Election Commission data shows that in the first six months of this year, the 14 Democrats collectively received at least $135,000 from PACs representing the country's top 10 defense vendors: Lockheed Martin, Raytheon, Boeing, Northrop Grumman, General Dynamics, L3Harris, Huntington Ingalls Industries, Leidos, Honeywell, and Booz Allen Hamilton.
Members of the Sackler family who are at the center of the nation's deadly opioid crisis have won sweeping immunity from opioid lawsuits linked to their privately owned company Purdue Pharma and its OxyContin medication. Federal Judge Robert Drain approved a bankruptcy settlement on Wednesday that grants the Sacklers "global peace" from any liability for the opioid epidemic. "This is a bitter result," Drain said. "I believe that at least some of the Sackler parties have liability for those [opioid OxyContin] claims. ... I would have expected a higher settlement." The complex bankruptcy plan ... grants "releases" from liability for harm caused by OxyContin and other opioids to the Sacklers, hundreds of their associates, as well as their remaining empire of companies and trusts. In return, they have agreed to pay roughly $4.3 billion, while also forfeiting ownership of Purdue Pharma. The Sacklers, who admit no wrongdoing and who by their own reckoning earned more than $10 billion from opioid sales, will remain one of the wealthiest families in the world. Critics of this bankruptcy settlement, meanwhile, said they would challenge Drain's confirmation because of the liability releases for the Sacklers. "This order is insulting to victims of the opioid epidemic who had no voice in these proceedings," said Washington state Attorney General Bob Ferguson. The Department of Justice urged Drain to reject the settlement. Attorneys general for nine states and the District of Columbia also opposed the plan.
Note: Purdue Pharma spent $1.2 million on lobbying just before making this deal. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.
Snopes, which has long presented itself as the internet's premier fact-checking resource, has retracted 60 articles after a BuzzFeed News investigation found that the site's co-founder plagiarized from news outlets as part of a strategy intended to scoop up web traffic. "As you can imagine, our staff are gutted and appalled by this," Vinny Green, the Snopes chief operating officer, said. He said the Snopes editorial team was conducting a review to understand just how many articles written by David Mikkelson, the site's co-founder and chief executive, featured content plagiarized from other news sites. As of Friday afternoon, the team had found 60, he said. By Friday morning, dozens of articles had been removed from the site, with pages that formerly featured those articles now showing the word "retracted" and an explanation that "some or all of its content was taken from other sources without proper attribution." Mr. Mikkelson, who owns 50 percent of Snopes Media Group, will continue to be Snopes's chief executive, but his ability to publish articles has been revoked, Mr. Green said. In a statement, Mr. Mikkelson acknowledged he had engaged in "multiple serious copyright violations of content that Snopes didn't have rights to use." From 2015 to 2019 – under the Snopes byline, his own name and another pseudonym – Mr. Mikkelson published dozens of articles that included language that appeared to have been copied directly from The New York Times, CNN, NBC News, the BBC and other news sources.
Note: There are many serious questions about the biases of Snopes and some of their unscrupulous tactics, as is covered in this Forbes article. For more along these lines, see concise summaries of deeply revealing news articles on media corruption from reliable sources.
As Purdue Pharma seeks approval for a controversial bankruptcy settlement, it has retained the services of highly compensated lobbying firms Brownstein Hyatt Farber Schreck and Capitol Hill Consulting Group. At the Purdue Pharma bankruptcy trial that began Thursday, Judge Robert Drain is widely expected to approve a proposed settlement of the Purdue Pharma bankruptcy that would release members of the billionaire Sackler family, the company's owners, from all current and future opioid-related civil claims. In the year and a half leading up to the trial, Purdue spent at least $1.2 million on federal lobbying expenses as it worked toward the settlement, an Intercept review of lobbying records shows. If the settlement is approved, the Sacklers will be making a contribution of $4.28 billion, which will leave them with over $6 billion at minimum in total assets – money that will be effectively untouchable by opioid crisis victims, even though it is Purdue going bankrupt, not the Sacklers. "This whole bankruptcy was the Sacklers trying to buy immunity," said activist Ed Bisch, who lost his son to an OxyContin overdose in 2001 and is a claimant and active opponent of the settlement. "The only question was what would be the price." Among the lobbyists paid by Purdue Pharma – maker of the opioid painkiller OxyContin – since it filed for bankruptcy reorganization in September 2019 are politically connected Brownstein Hyatt, which received $480,000, and Capitol Hill Consulting Group, which got $300,000.
Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.
The American Medical Association's new training on pain management arrived in the midst of a burgeoning crisis. It was September 2007, and doctors were prescribing enough opioid painkillers each year for every American adult to have a bottle of the addictive pills. Overdoses were at a historic high and showed no signs of slowing down. Just four months earlier, executives at Purdue Pharma had pleaded guilty to felony charges for misleading regulators and physicians about the dangers of OxyContin. In light of this news, one might have expected the AMA ... to bring attention to the crisis in its newly updated continuing education course on how to treat pain. Instead, the 12-module training suggested that doctors were still too tentative about prescribing narcotics. "The effectiveness of opioid therapy may be undermined by misconceptions about their risks, particularly risks associated with abuse and addiction," read materials from one session. Down in the fine print, the AMA-branded course materials reveal that the training's development and distribution was made possible by an educational grant from Purdue Pharma. By now, the story of how Purdue Pharma sowed the seeds for the overdose crisis is the stuff of history books. But the years of Purdue's involvement with the AMA have been strangely absent from that narrative. Between 2002 and 2018, the AMA and the organization's philanthropic arm, the AMA Foundation, received more than $3 million from Purdue Pharma.
Pension funds, investment firms and Wall Street banks are snapping up family homes in Europe and the United States at a rapid pace as prices rocket higher. At the same time, the soaring cost of home ownership means that growing numbers of younger Americans and Brits renting rather than buying houses as they start families. Some of them may find their next landlord is based on Wall Street or in London's financial district. Analysts argue that this will improve standards in the rental sector. But some tenants who rent from corporate landlords dispute this, alleging substandard services and excessive rent increases. If investors are hoovering up existing properties that would otherwise have been sold to individuals, that could squeeze out first-time buyers. Household incomes in the United States and United Kingdom have not kept pace with rising home values in recent years, a trend made worse by the pandemic, which has sent average house prices in both markets to record highs. Invitation Homes, America's biggest single-family home leasing company with some 81,000 houses, is currently facing two lawsuits brought by tenants in California and Maryland who claim that the company's late rent fees constitute illegal penalties under state laws. Current and former tenants of the company ... painted a picture of an uncaring landlord, slow to make repairs and quick to threaten eviction when rent payments are overdue or withheld because of unresolved maintenance issues.
The cost of vaccinating the world against COVID-19 could be at least five times cheaper if pharmaceutical companies weren't profiteering from their monopolies on COVID-19 vaccines, campaigners from The People's Vaccine Alliance said today. New analysis by the Alliance shows that the firms Pfizer/BioNTech and Moderna are charging governments as much as $41 billion above the estimated cost of production. Colombia, for example, has potentially overpaid by as much as $375 million for its doses of the Pfizer/BioNTech and Moderna vaccines, in comparison to the estimated cost price. Despite a rapid rise in COVID cases and deaths across the developing world, Pfizer/BioNTech and Moderna have sold over 90 percent of their vaccines so far to rich countries, charging up to 24 times the potential cost of production. Neither company have agreed to fully transfer vaccine technology and know-how with any capable producers in developing countries, a move that could increase global supply, drive down prices and save millions of lives. Analysis of production techniques for the leading mRNA type vaccines produced by Pfizer/BioNTech and Moderna â€•which were only developed thanks to public funding to the tune of $8.3 billionâ€• suggest these vaccines could be made for as little as $1.20 a dose. Yet COVAX, the scheme set up to help countries get access to COVID vaccines, has been paying, on average, nearly five times more.
Strong sales of its COVID-19 vaccine and other medicines helped Pfizer nearly double its second-quarter revenue and boost its profit an impressive 59%, beating Wall Street expectations and leading the drug giant to sharply hike its 2021 sales and profit forecasts. Amid the surging coronavirus pandemic, the COVID-19 vaccine became Pfizer's top seller, bringing in nearly half its revenue – $7.84 billion from direct sales and revenue split with its partner, Germany's BioNTech. Pfizer now anticipates revenue from the two-dose vaccine this year to reach $33.5 billion for the 2.1 billion doses it's contracted to provide by year end. That doesn't include a contract struck last week to provide an additional 200 million doses to the U.S. The New York company on Wednesday disclosed that ongoing testing of a booster shot, given six months after the second vaccine dose, showed it raised antibody levels against the more-transmissible Delta variant to 11 times higher in older people and five times higher in younger people, compared to levels after two doses. Pfizer has delivered more than 1 billion doses of the vaccine globally and expects to make 3 billion doses this year, with many more going to low- and middle-income countries from now through year's end. Most doses of all the COVID-19 vaccines produced in Europe and the U.S. so far have gone to wealthy countries.
Note: When public health is at stake, should private companies be making huge profits like this? Read more in this information article. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering and coronavirus vaccines from reliable major media sources.
Few pause to think that their phones can be transformed into surveillance devices, with someone thousands of miles away silently extracting their messages, photos and location, activating their microphone to record them in real time. Such are the capabilities of Pegasus, the spyware manufactured by NSO Group, the Israeli purveyor of weapons of mass surveillance. The Guardian will be revealing the identities of many innocent people who have been identified as candidates for possible surveillance by NSO clients in a massive leak of data. Without forensics on their devices, we cannot know whether governments successfully targeted these people. But the presence of their names on this list indicates the lengths to which governments may go to spy on critics, rivals and opponents. Journalists across the world were selected as potential targets by these clients prior to a possible hack using NSO surveillance tools. People whose phone numbers appear in the leak ... include lawyers, human rights defenders, religious figures, academics, businesspeople, diplomats, senior government officials and heads of state. One phone that has contained signs of Pegasus activity belonged to our esteemed Mexican colleague Carmen Aristegui, whose number was in the data leak and who was targeted following her exposÄ‚© of a corruption scandal involving her country's former president Enrique PeÄ‚±a Nieto. At least four of her journalist colleagues appear in the leak
Johnson & Johnson is exploring a plan to offload liabilities from widespread Baby Powder litigation into a newly created business that would then seek bankruptcy protection. During settlement discussions, one of the health-care conglomerate's attorneys has told plaintiffs' lawyers that J&J could pursue the bankruptcy plan, which could result in lower payouts for cases that do not settle beforehand. Plaintiffs' lawyers would initially be unable to stop J&J from taking such a step. J&J faces legal actions from tens of thousands of plaintiffs alleging its Baby Powder and other talc products contained asbestos and caused cancer. The plaintiffs include women suffering from ovarian cancer and others battling mesothelioma. Should J&J proceed, plaintiffs who have not settled could find themselves in protracted bankruptcy proceedings with a likely much smaller company. Future payouts to plaintiffs would be dependent on how J&J decides to fund the entity housing its talc liabilities. J&J is now considering using Texas's "divisive merger" law, which allows a company to split into at least two entities. For J&J, that could create a new entity housing talc liabilities that would then file for bankruptcy to halt litigation. The maneuver is known among legal experts as a Texas two-step bankruptcy. A 2018 Reuters investigation found J&J knew for decades that asbestos, a known carcinogen, lurked in its Baby Powder and other cosmetic talc products.
Note: Can we trust this company with vaccines? For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.
Last week the hospital bill finally came. The cost of an uncomplicated vaginal birth? $37,617.69. The bulk of the charge was for three nights' "room and board" in a semi-private room (containing two beds separated by a curtain) which was $10,350 a night. Our health insurance covers about $31,000 – leaving us with a balance of around $6,000. Although, of course, that doesn't make the ridiculously high prices OK. We're still covering the costs indirectly via our enormous insurance premiums which, we were recently informed by Oxford Health, part of UnitedHealth Group, are going to go up by 16% next year. The UnitedHealth Group's chief executive made over $50m in salary, bonus and stock option compensation in 2019. It's not just the extortionate prices in America's health system that are problematic. It's the lack of transparency. My partner called our insurance company multiple times before the birth to try to find out how much we would expect to pay. We were told on each occasion that we wouldn't have to pay anything. Which was obviously baloney. America's healthcare system isn't just a nightmare to navigate – it's inefficient and inequitable. The US may spend more on healthcare as a share of the economy than any other developed country, but it also has the highest maternal mortality rate in the developed world and maternal deaths have been increasing since 2000. And Black women are three times more likely to die from a pregnancy-related cause than white women.
Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.
A handful of powerful companies control the majority market share of almost 80% of dozens of grocery items bought regularly by ordinary Americans, new analysis reveals. A joint investigation by the Guardian and Food and Water Watch found that consumer choice is largely an illusion – despite supermarket shelves and fridges brimming with different brands. In fact, a few powerful transnational companies dominate every link of the food supply chain: from seeds and fertilizers to slaughterhouses and supermarkets to cereals and beers. The size, power and profits of these mega companies have expanded thanks to political lobbying and weak regulation which enabled a wave of unchecked mergers and acquisitions. The size and influence of these mega-companies enables them to largely dictate what America's 2 million farmers grow and how much they are paid, as well as what consumers eat and how much our groceries cost. It also means those who harvest, pack and sell us our food have the least power: at least half of the 10 lowest-paid jobs are in the food industry. Farms and meat processing plants are among the most dangerous and exploitative workplaces in the country. Overall, only 15 cents of every dollar we spend in the supermarket goes to farmers. The rest goes to processing and marketing our food. Less competition among agribusinesses means higher prices and fewer choices for consumers. Just four companies – Walmart, Costco, Kroger and Ahold Delhaize – control 65% of the retail market.
Note: For more along these lines, see concise summaries of deeply revealing news articles on food system corruption from reliable major media sources.
The cost of vaccinating the world against COVID-19 could be at least five times cheaper if pharmaceutical companies weren't profiteering from their monopolies on COVID-19 vaccines, campaigners from the People's Vaccine Alliance said today. New analysis by the Alliance shows that the firms Pfizer/BioNTech and Moderna are charging governments as much as $41 billion above the estimated cost of production. Colombia, for example, has potentially overpaid by as much as $375 million for its doses of the Pfizer/BioNTech and Moderna vaccines, in comparison to the estimated cost price. Despite a rapid rise in COVID-19 cases and deaths across the developing world, Pfizer/BioNTech and Moderna have sold over 90 percent of their vaccines so far to rich countries, charging up to 24 times the potential cost of production. Last week Pfizer/BioNTech announced it would licence a South African company to fill and package 100 million doses for use in Africa, but this is a drop in the ocean of need. Neither company have agreed to fully transfer vaccine technology and know-how with any capable producers in developing countries, a move that could increase global supply, drive down prices and save millions of lives. Analysis of production techniques for the leading mRNA type vaccines produced by Pfizer/BioNTech and Moderna Ă˘â‚Źâ€˘which were only developed thanks to public funding to the tune of $8.3 billionĂ˘â‚Źâ€˘ suggest these vaccines could be made for as little as $1.20 a dose.
A colonoscopy might cost you or your insurer a few hundred dollars – or several thousand, depending on which hospital or insurer you use. Long hidden, such price variations are supposed to be available in stark black and white under a Trump administration price transparency rule that took effect at the start of this year. It requires hospitals to post a range of actual prices – everything from the rates they offer cash-paying customers to costs negotiated with insurers. While imperfect and potentially of limited use right now to the average consumer, the disclosures that are available illustrate the huge differences in prices – nationally, regionally and within the same hospital. Prices are all over the map. In Virginia, for example, the average price of a diagnostic colonoscopy is $2,763, but the range across the state is from $208 to $10,563. Patients can try to find the price information themselves by searching hospital websites, but even locating the correct tab on a hospital's website is tricky. But if you do want to try, here's one tip: "You can Google the hospital name and the words 'price transparency' and see where that takes you," says Caitlin Sheetz, director and head of analytics at the consulting firm ADVI Health. When it comes to compliance, "we're seeing the range of the spectrum," says Jeffrey Leibach, a partner at the consulting firm Guidehouse, which found earlier this year that about 60% of 1,000 hospitals surveyed had posted at least some data, but 30% had reported nothing at all.
Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.
The chairman of a House subcommittee is demanding that executives of Exxon Mobil Corp., Shell, Chevron and other major oil and gas companies testify before Congress about the industry's decades-long effort to wage disinformation campaigns around climate change. Representative Ro Khanna, Democrat of California, said Friday he was prepared to use subpoena power to compel the companies to appear before lawmakers if they don't do so voluntarily. The move comes a day after a secretive video recording was made public in which a senior Exxon lobbyist said the energy giant had fought climate science through "shadow groups" and had targeted influential senators in an effort to weaken President Biden's climate agenda. "The video was appalling," Mr. Khanna said in an interview on Friday. He called it the latest evidence of the fossil fuel industry's efforts to "engage in climate denialism and to manipulate public opinion and to exert undue influence in shaping policy in Congress." Mr. Khanna said the House Oversight and Reform Subcommittee on the Environment, which he chairs, will issue letters next week to top executives at Exxon Mobil, Shell, Chevron and other oil and gas companies and trade groups demanding documents and testimony. One major target of the panel's inquiry are dark money groups that have been funded by fossil fuel companies to disseminate falsehoods about climate science and policy solutions. The hearing is expected to be held in the fall.
Note: Learn more in this Washington Post article. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and climate change from reliable major media sources.
Managers and career staff in the Environmental Protection Agency's Office of Chemical Safety and Pollution Prevention tampered with the assessments of dozens of chemicals to make them appear safer, according to four scientists who work at the agency. The whistleblowers, whose jobs involve identifying the potential harms posed by new chemicals, provided ... detailed evidence of pressure within the agency to minimize or remove evidence of potential adverse effects of the chemicals, including neurological effects, birth defects, and cancer. Information about hazards was deleted from agency assessments without informing or seeking the consent of the scientists who authored them. Some of these cases led the EPA to withhold critical information from the public about potentially dangerous chemical exposures. In other cases, the removal of the hazard information or the altering of the scientists' conclusions in reports paved the way for the use of chemicals, which otherwise would not have been allowed on the market. William Irwin, [one] of the four whistleblowers, who has worked at the EPA for over 11 years as a toxicologist, was ... moved out of the office after repeatedly resisting pressure to change his assessments to favor industry. Irwin said that while it had seemed obvious that the pressure stemmed from chemical companies, the science adviser in the office made the point irrefutably clear during an argument over one particular chemical assessment.
Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption from reliable major media sources.
Treasury Secretary Janet Yellen announced Thursday that a group of 130 nations has agreed to a global minimum tax on corporations, part of a broader agreement to overhaul international tax rules. If widely enacted, the GMT would effectively end the practice of global corporations seeking out low-tax jurisdictions like Ireland and the British Virgin Islands to move their headquarters to, even though their customers, operations and executives are located elsewhere. "For decades, the United States has participated in a self-defeating international tax competition, lowering our corporate tax rates only to watch other nations lower theirs in response. The result was a global race to the bottom: Who could lower their corporate rate further and faster? No nation has won this race," said Yellen in a statement on the accord. "Today's agreement by 130 countries representing more than 90 percent of global GDP is a clear sign: the race to the bottom is one step closer to coming to an end," Yellen said. The deal also reportedly includes a framework to eliminate digital services taxes, which targeted the biggest American tech companies. In their place, officials agreed to a new tax plan that would be linked to the places where multinationals are actually doing business, rather than where they are headquartered. The groundwork for adopting a GMT has already been laid by the Organization for Economic Cooperation and Development, which released a blueprint ... outlining a two-pillar approach to international taxation.
Note: The most profitable companies sometimes pay no US taxes at all. A recent ProPublica investigation revealed that American billionaires also pay almost nothing in taxes. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.
Interviews with more than two dozen experts on pesticide regulation – including 14 who worked at the EPA's Office of Pesticide Programs, or OPP – described a federal environmental agency that is often unable to stand up to the intense pressures from powerful agrochemical companies, which spend tens of millions of dollars on lobbying each year and employ many former EPA scientists once they leave the agency. The enormous corporate influence has weakened and, in some cases, shut down the meaningful regulation of pesticides in the U.S. and left the country's residents exposed to levels of dangerous chemicals not tolerated in many other nations. This reporting has brought to light several instances in which the overlooking, burying, or scuttling of science has had direct consequences for human health. The alarming discoveries include an EPA report warning about the link between the pesticide glyphosate and cancer that never saw the light of day; the failure to consider evidence that a neonicotinoid pesticide causes brain damage; the refusal to investigate evidence that another pesticide that is an ingredient in Roundup may cause cancer ... and the agency's waiving of the vast majority of toxicity tests at the request of industry. The scientists who have identified these hazards described immense pressure from within the agency to overlook the risks they found. And several said they faced retribution for calling attention to the dangers of pesticides.
ProPublica cracked open the vault on America's biggest tax grifters, revealing how the Midas men dip, dodge and duck, paying pennies on the dollar, if that, while we suckers have to pony up. How rich. "In 2007, Jeff Bezos, then a multibillionaire and now the world's richest man, did not pay a penny in federal income taxes," ProPublica reported. "He achieved the feat again in 2011. In 2018, Tesla founder Elon Musk, the second-richest person in the world, also paid no federal income taxes. "Michael Bloomberg managed to do the same in recent years. Billionaire investor Carl Icahn did it twice. George Soros paid no federal income tax three years in a row." "Taken together," ProPublica concluded, "it demolishes the cornerstone myth of the American tax system: that everyone pays their fair share and the richest Americans pay the most. The I.R.S. records show that the wealthiest can – perfectly legally – pay income taxes that are only a tiny fraction of the hundreds of millions, if not billions, their fortunes grow each year." ProPublica shed light on the fact that "the superrich earn virtually all their wealth from the constantly rising value of their assets, particularly in the stock market, and that the sales of those assets are taxed at a lower rate than ordinary income from a paycheck." And while the value of those assets grows by the billion, untaxed, these rich folks can borrow against them.
The wealthiest Americans – including Warren Buffett, Elon Musk and Jeff Bezos – paid little in federal income taxes at times in recent years despite soaring fortunes, according to Internal Revenue Service data obtained by ProPublica. The information published Tuesday shows how billionaires are able to legally reduce their tax burden, highlighting how the American tax system can hit ordinary wage earners harder than the richest people in the country. That's often because the richest Americans tend to have their wealth tied up in stocks and real estate, allowing them to avoid taxes on unrealized profits. The U.S. tax system focuses on income, not what is known as unrealized gains from unsold stocks, real estate or other assets. The records ... purport to show Buffett, head of Berkshire Hathaway, as having paid $23.7 million in federal income taxes on total income of $125 million from 2014 to 2018, which would indicate a personal income tax rate of 19 percent. ProPublica estimated that Buffett saw his wealth soar by $24.3 billion during that period and so his "true tax rate" was 0.10 percent. Musk, chief executive of Tesla, paid $455 million on $1.52 billion in income during the same period, when his wealth grew by $13.9 billion, accounting for a "true tax rate" of 3.27 percent. Bezos, chief executive of Amazon and the owner of The Washington Post, paid $973 million in taxes on $4.22 billion in income, as his wealth soared by $99 billion, resulting in a 0.98 percent "true tax rate."
Note: Learn about important facts this article leaves out in this excellent piece. For more along these lines, see concise summaries of deeply revealing news articles on income inequality from reliable major media sources.
Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.